Literature DB >> 12916942

Influence of complex solubility on formulations based on lambda carrageenan and basic drugs.

Carola Aguzzi1, Maria Cristina Bonferoni, Maria Rosario Osorio Fortich, Silvia Rossi, Franca Ferrari, Carla Caramella.   

Abstract

The purpose of the present work was to compare the behavior of some drug/carrageenan complexes having different solubility in water, in a controlled release formulation. Diltiazem HCl, bupropion HCl, metoprolol tartrate, and tramadol HCl were used as model drugs. The complexes were characterized by means of solubility measurements, release test at constant surface area, and water uptake measurements, and the results were related to their performance in controlled release formulations. For the more soluble complexes (involving metoprolol and tramadol) the occurrence of gelation after hydration was observed, while diltiazem complex apparently did not gellify; bupropion behavior was intermediate. A correspondence was found between the observed differences in complex solubility and hydration-gelation behavior and the drug release profiles. For all the drugs considered, the release was completed in about 10 to 12 hours, but different kinetics were observed depending on the solubility of the complexes. All the considered complexes seem suitable for controlled release purposes, although the data obtained show the relevance of the complex solubility to drug release profiles.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12916942      PMCID: PMC2784056          DOI: 10.1208/pt030327

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  8 in total

1.  The binding of organic ions by proteins.

Authors:  I M KLOTZ; F M WALKER; R B PIVAN
Journal:  J Am Chem Soc       Date:  1946-08       Impact factor: 15.419

2.  On the employment of lambda carrageenan in a matrix system. III. Optimization of a lambda carrageenan-HPMC hydrophilic matrix.

Authors:  M C Bonferoni; S Rossi; F Ferrari; M Bertoni; G K Bolhuis; C Caramella
Journal:  J Control Release       Date:  1998-02-12       Impact factor: 9.776

3.  A designer's polymer as an oral drug carrier (tablet) with pseudo-zero-order release kinetics.

Authors:  Y N Nujoma; C J Kim
Journal:  J Pharm Sci       Date:  1996-10       Impact factor: 3.534

Review 4.  Studies of beneficial interactions between active medicaments and excipients in pharmaceutical formulations.

Authors:  G N Kalinkova
Journal:  Int J Pharm       Date:  1999-09-30       Impact factor: 5.875

5.  Analysis of Fickian and non-Fickian drug release from polymers.

Authors:  N A Peppas
Journal:  Pharm Acta Helv       Date:  1985

6.  Characterization of a diltiazem-lambda carrageenan complex.

Authors:  M C Bonferoni; S Rossi; F Ferrari; G P Bettinetti; C Caramella
Journal:  Int J Pharm       Date:  2000-05-10       Impact factor: 5.875

7.  Drug release from drug-polyanion complex tablets: poly(acrylamido-2-methyl-1-propanesulfonate sodium -co- methyl methacrylate).

Authors:  N Konar; C Kim
Journal:  J Control Release       Date:  1999-02-01       Impact factor: 9.776

8.  Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes.

Authors:  M C Bonferoni; S Rossi; F Ferrari; E Stavik; A Pena-Romero; C Caramella
Journal:  AAPS PharmSciTech       Date:  2000-06-17       Impact factor: 3.246

  8 in total
  6 in total

Review 1.  Novel platforms for oral drug delivery.

Authors:  P Colombo; F Sonvico; G Colombo; R Bettini
Journal:  Pharm Res       Date:  2009-01-09       Impact factor: 4.200

2.  Molecular properties of ciprofloxacin-Indion 234 complexes.

Authors:  Sambhaji Pisal; Rana Zainnuddin; Pradeep Nalawade; Kakasaheb Mahadik; Shivajirao Kadam
Journal:  AAPS PharmSciTech       Date:  2004-09-22       Impact factor: 3.246

3.  In vitro and in vivo evaluation of guar gum matrix tablets for oral controlled release of water-soluble diltiazem hydrochloride.

Authors:  Saleh M Al-Saidan; Yellela S R Krishnaiah; Srinivas S Patro; Vemulapalli Satyanaryana
Journal:  AAPS PharmSciTech       Date:  2005-07-14       Impact factor: 3.246

4.  Electrolyte-stimulated biphasic dissolution profile and stability enhancement for tablets containing drug-polyelectrolyte complexes.

Authors:  Christoph Kindermann; Karin Matthée; Frank Sievert; Jörg Breitkreutz
Journal:  Pharm Res       Date:  2012-01-07       Impact factor: 4.200

5.  Drug release kinetics and front movement in matrix tablets containing diltiazem or metoprolol/λ-carrageenan complexes.

Authors:  Ruggero Bettini; Maria Cristina Bonferoni; Paolo Colombo; Laura Zanelotti; Carla Caramella
Journal:  Biomed Res Int       Date:  2014-06-19       Impact factor: 3.411

6.  Matrix Tablets Based on Chitosan-Carrageenan Polyelectrolyte Complex: Unique Matrices for Drug Targeting in the Intestine.

Authors:  Alena Komersová; Roman Svoboda; Barbora Skalická; Martin Bartoš; Eva Šnejdrová; Jitka Mužíková; Kevin Matzick
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.